Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
-
Field
-
on FNR’s prestigious PEARL program, and has the option for an affiliated professorship. Both LIH and DFKI pledge their full commitment to ensuring that this new position becomes a cornerstone in the
-
the first Réseau de Compétences Maladies Neurodégénératives/ParkinsonNet (RdC-MN) funded by by the Ministry of Health and Social Security. The “Programme for Dementia Prevention ” (pdp) is a first nation-wide
-
immune cells in Alzheimer’s disease. Our lab investigates how immune cells and signals shape brain development, activity, and aging. In this project, we aim to dissect the contribution of adaptive immune
-
co-managed by two deputies: Christian Vestergaard, a theoretical physicist, and François Laurent, an applied mathematician and software engineer. The laboratory’s research is centred on uncovering
-
rapidly growing and are strategic areas of development for both the University and the government of Luxembourg. To effectively foster high quality teaching within the recently created study programmes
-
used to develop networks capable of self-learning and self-optimisation, adapting to real-time changes in traffic and demand. The successful candidate will contribute to designing solutions that optimise
-
environmental sciences, public health, and socio-economic research to develop innovative strategies for mitigating health risks associated with global change. A demonstrated ability to engage with stakeholders in
-
. This study investigated a range of research questions using RNC breast cancer data and explored potential secondary data linkages. The RELIANCE study was initiated under the umbrella of the “Plan National
-
for the European Higher Education Area ) in pharmacy, chemistry or a similar subject and a minimum of 4 years’ professional experience in a similar role (e.g. developing and/or maintaining stakeholder engagement
-
The project will be developed in the host laboratory(SIMHEL/U978) whose main pathophysiological models are two CD5+chronic B cell neoplasms (chronic lymphocytic leukemiaand mantle cell lymphoma